Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Ischemic Digital Ulcers Associated With Systemic Sclerosis

NCT01474109 is registered in ClinicalTrials.gov with Actelion as lead sponsor.

NCT NCT01474109
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01474109 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Ischemic Digital Ulcers Associated With Systemic Sclerosis
Lead sponsor
Actelion
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2011
Completion date
November 30, 2013
Enrollment
289 (actual)
Sites
77

Conditions

As the registry lists them; a condition with its own page is linked.

systemic sclerosis, ulcers